Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

Some dibenzo compounds might help treat cancer with fewer side effects.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Minoxidil reduces lysine hydroxylase in skin cells.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Sublingual minoxidil effectively treats hair loss with mild side effects.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Topical finasteride is as effective and safe as minoxidil for treating female pattern hair loss.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.